Metastatic melanoma therapeutics encompass a broad portfolio of targeted agents, immunotherapies, and combination regimens designed to treat advanced melanoma that has spread beyond the skin. Key products include BRAF and MEK inhibitors, PD-1/CTLA-4 checkpoint inhibitors, adoptive cell therapies, and oncolytic viruses. These therapies offer advantages such as increased overall surviva... https://www.patreon.com/posts/metastatic-is-to-130758861?utm_medium=clipboard_copy&utm_source=copyLink&utm_campaign=postshare_creator&utm_content=join_link